ChemoCentryx Inc (OQ:CCXI)

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CCXI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 23/20 Jan 21/20 Cappel Markus J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,259  
Jan 23/20 Jan 21/20 Cappel Markus J. Direct Ownership Common Stock S - Open market or private sale -1,259 $44.00
Jan 23/20 Jan 21/20 Cappel Markus J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,259 $8.19
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -105,735  
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -22,179 $42.13
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -83,556 $41.46
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 105,735 $10.27
Jan 17/20 Jan 17/20 Kanaya Susan M Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -15,737  
Jan 17/20 Jan 17/20 Kanaya Susan M Indirect Ownership Common Stock S - Open market or private sale -15,737 $41.03
Jan 17/20 Jan 17/20 Kanaya Susan M Indirect Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 15,737 $14.28
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CCXI within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET January 25th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jan 23/20 Jan 21/20 Cappel Markus J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -1,259  
Jan 23/20 Jan 21/20 Cappel Markus J. Direct Ownership Common Stock S - Open market or private sale -1,259 $44.00
Jan 23/20 Jan 21/20 Cappel Markus J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 1,259 $8.19
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -105,735  
Jan 17/20 Jan 16/20 Schall Thomas J. Direct Ownership Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -30,317  
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -22,179 $42.13
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -83,556 $41.46
Jan 17/20 Jan 17/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 105,735 $10.27
Jan 17/20 Jan 16/20 Schall Thomas J. Direct Ownership Common Stock S - Open market or private sale -30,317 $41.01
Jan 17/20 Jan 16/20 Schall Thomas J. Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 30,317 $10.27
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CCXI

Competitors

Competitors with Recent Insider Filings
Aptinyx (OQ:APTX)
Twist Bioscience (OQ:TWST)
Apellis Pharmaceuticals (OQ:APLS)